Terri Cornforth
About Terri Cornforth
Terri Cornforth is a Principal Scientist specializing in the use of primary human tumor tissue within organotypic models. She has extensive experience in preclinical research in immuno-oncology and has worked at Adaptimmune since 2021, following a six-year tenure as a Senior Scientist at the same company.
Current Role at Adaptimmune
Terri Cornforth currently holds the position of Principal Scientist at Adaptimmune, where she has been employed since 2021. In this role, she specializes in the use of primary human tumor tissue within organotypic models. Her work is integral to the company's focus on preclinical research in the field of immuno-oncology. Cornforth's expertise contributes to the development of innovative therapeutic strategies aimed at enhancing cancer treatment.
Previous Experience at Adaptimmune
Prior to her current role, Terri Cornforth worked at Adaptimmune as a Senior Scientist from 2015 to 2021. During her six years in this position, she gained valuable experience and contributed to various projects within the organization. Her tenure at Adaptimmune laid the groundwork for her subsequent advancement to Principal Scientist.
Educational Background
Terri Cornforth studied at Oxford University, where she pursued clinical laboratory sciences and earned a DPhil from 2008 to 2013. This advanced education provided her with a strong foundation in scientific research methodologies. Additionally, she completed her Bachelor of Science (BSc) in Biochemistry at the University of Newcastle-upon-Tyne from 2005 to 2008.
Research Experience and Specialization
In her research career, Terri Cornforth has specialized in the use of primary human tumor tissue within organotypic models, focusing on applications in immuno-oncology. She also has experience working with 3D liver models in a previous role, which enhances her expertise in developing complex biological systems for research purposes.
Role at University of Oxford
Before her tenure at Adaptimmune, Terri Cornforth worked at the University of Oxford as a D.Phil student from 2008 to 2012. This role allowed her to deepen her research skills and contribute to academic projects that informed her later work in the biotechnology sector.